Spraino develops tribological patches for footwear that actively manage friction at the shoe-surface interface. Their technology reduces ankle twist forces by over 90% to prevent injuries and stabilizes gait to reduce falls for individuals with impairments.
Funding
Funding not disclosed
Founders
Product
Problem
Athletes and individuals with gait impairments are susceptible to ankle injuries and falls due to uncontrolled foot mechanics and excessive friction during movement. Existing footwear solutions often fail to adequately mitigate these risks, leading to prolonged recovery times and reduced mobility.
Solution
Spraino develops advanced tribological patches designed to be integrated into footwear, actively managing friction at the shoe-surface interface. These patches are engineered to reduce the forces experienced during ankle twists by over 90%, thereby preventing a significant percentage of serious ankle injuries. For individuals with gait impairments, Spraino's technology aids in stabilizing the foot during walking, reducing the likelihood of trips and falls. The company's scientific approach focuses on controlling biomechanical forces through material science and engineering, aiming to enhance both safety and performance in athletic and daily activities.
Target Audience
The primary target audience includes athletes across various sports, footwear brands seeking to enhance product safety and performance, and medical professionals recommending solutions for patients with gait abnormalities or fall risks.
Features
- Tribological patches with engineered low-friction surfaces for footwear integration.
- Patented technology designed to reduce ankle twist forces by over 90%.
- Clinical data demonstrating up to a 67% reduction in injury recovery time.
- GaitAid™ technology specifically developed to assist individuals with gait impairments and prevent falls.
- Materials science expertise applied to footwear biomechanics for optimized force transmission control.
- Collaboration with biomechanics and orthopedic research institutions to validate product efficacy.